(Q34204370)

31 July 2017

1 reference

title

LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action (English)

1 reference

Marina Montagnani Marelli

31 July 2017

author

0 references

author name string

Limonta P

series ordinal

1

1 reference

31 July 2017

Montagnani Marelli M

series ordinal

2

1 reference

31 July 2017

Moretti RM

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

published in

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

709-720

1 reference

Gonadotropin gene modulation by steroids and gonadotropin-releasing hormone

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Gonadotropin-releasing hormone and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Gonadotropin-releasing hormone genes: phylogeny, structure, and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Second gene for gonadotropin-releasing hormone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Mechanism of GnRH receptor signaling: combinatorial cross-talk of Ca2+ and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by exclusively coupling to G(q/11) proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Gonadotrophin-releasing hormone: its actions and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Tissue-specific pattern of variant transcripts of the human gonadotropin-releasing hormone receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Pharmacokinetics of gonadotropin-releasing hormone and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

GnRH receptor and apoptotic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Establishment of immunological probes to study human gonadotropin-releasing hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Lupron retards proliferation of ovarian epithelial tumor cells cultured in serum-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Influence of luteinizing hormone-releasing hormone agonists on human mammary carcinoma cell lines and their xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Growth inhibition of human prostate tumor cells by an agonist of gonadotrophin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Effects of LHRH-analogues on mitogenic signal transduction in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.4.709

10.1517/13543784.10.4.709

21 January 2018

Identifiers

DOI

1 reference

release_77uufivhyfdm7kjfffyj4gnu5y

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/77uufivhyfdm7kjfffyj4gnu5y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference